Sandoz dials up product launch plans ahead of market debut
By Ludwig Burger and Paul Arnold FRANKFURT (Reuters) – Sandoz plans to launch at least five additional biologic drugs, its CEO Richard Saynor said, as the generics drugs business of…
By Ludwig Burger and Paul Arnold FRANKFURT (Reuters) – Sandoz plans to launch at least five additional biologic drugs, its CEO Richard Saynor said, as the generics drugs business of…
HONG KONG/SHANGHAI (Reuters) – Dealmakers at China International Capital Corp (CICC) will see bonuses slashed by as much as 40%, three sources said, in one of the financial sector’s biggest…